Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Neurology ; 81(23): 2039-44, 2013 Dec 03.
Article in English | MEDLINE | ID: mdl-24198292

ABSTRACT

OBJECTIVE: Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is caused by autosomal-dominantly inherited mutations in the colony stimulating factor 1 receptor (CSF1R) gene, and is clinically characterized by a progressive cognitive and motor decline leading to death within several years. METHODS: In a continuous series of 25 patients with adult-onset leukoencephalopathy of unknown cause, we genetically confirmed HDLS in 6 families. Affected and nonaffected individuals were examined clinically and by brain MRI studies. RESULTS: HDLS presented as prominent dementia and apraxia, often with extrapyramidal and pyramidal signs, rarely with ataxia. White matter MRI changes were detectable early in the disease course. Family history was negative in 4 of 6 index patients. In 2 of 6 index patients, we could confirm the occurrence of de novo mutations in the CSF1R gene. One family showed possible incomplete penetrance: the 69-year-old father of the index patient carried a CSF1R mutation but was clinically unaffected. In one family, the parents were apparently unaffected and not available for genetic testing. CONCLUSIONS: Typical clinical phenotype and early brain MRI alterations can help to guide the diagnosis of HDLS. Because we confirmed de novo mutations in one-third of patients with CSF1R mutations, this diagnosis should be considered even in the absence of a family history. Furthermore, we present evidence for reduced penetrance of a CSF1R mutation. These results have substantial impact for genetic counseling of asymptomatic individuals at risk and should foster research into disease-modifying factors.


Subject(s)
Mutation/genetics , Adult , Female , Humans , Leukoencephalopathies/diagnosis , Leukoencephalopathies/genetics , Male , Middle Aged , Young Adult
2.
Radiology ; 266(1): 280-8, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23151826

ABSTRACT

PURPOSE: To characterize changes in the magnetic resonance (MR) relaxation properties of progressive supranuclear palsy (PSP) and tissue from neurologically normal brains by using high-resolution (21.1-T, 900-MHz) MR microscopy of postmortem human midbrain and basal ganglia. MATERIALS AND METHODS: This HIPAA-compliant study was approved by the institutional review board at the Mayo Clinic and informed consent was obtained. Postmortem tissue from age-matched PSP (n = 6) and control (n = 3) brains was imaged by using three-dimensional fast low-angle shot MR imaging with isotropic resolution of 50 µm. Relaxation times and parametric relaxation maps were generated from spin-echo and gradient-recalled-echo sequences. MR findings were correlated with histologic features by evaluating the presence of iron by using Prussian blue and ferritin and microglia burden as determined by a custom-designed color deconvolution algorithm. T2 and T2*, signal intensities, percent pixels (that could not be fitted in a pixel-by-pixel regression analysis due to severe hypointensity), and histologic data (total iron, ferritin, and microglia burden) were statistically analyzed by using independent sample t tests (P < .05). RESULTS: PSP specimens showed higher iron burden in the cerebral peduncles and substantia nigra than did controls. However, only the putamen was significantly different, and it correlated with a decrease of T2* compared with controls (-48%; P = .043). Similarly, substantia nigra showed a significant decrease of T2* signal in PSP compared with controls (-57%; P = .028). Compared with controls, cerebral peduncles showed increased T2 (38%; P = .026) and T2* (34%; P = .014), as well as higher T2 signal intensity (57%; P = .049). Ferritin immunoreactivity was the opposite from iron burden and was significantly lower compared with controls in the putamen (-74%; P = .025), red nucleus (-61%; P = .018), and entire basal ganglia section (-63%; P = .016). CONCLUSION: High-field-strength MR microscopy yielded pronounced differences in substantia nigra and globus pallidus of PSP compared with control brains. Histologic data also suggested that the predominant iron in PSP is hemosiderin, not ferritin. Iron in the brain is a contrast enhancer and potential biomarker for PSP.


Subject(s)
Globus Pallidus/pathology , Imaging, Three-Dimensional/methods , Magnetic Resonance Imaging/methods , Microscopy/methods , Substantia Nigra/pathology , Supranuclear Palsy, Progressive/pathology , Aged , Aged, 80 and over , Cadaver , Female , Humans , Male , Reproducibility of Results , Sensitivity and Specificity
3.
J Neuropathol Exp Neurol ; 71(12): 1113-22, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23147507

ABSTRACT

White matter hyperintensities (WMHs) associate with both cognitive slowing and motor dysfunction in the neurologically normal elderly. A full understanding of the pathology underlying this clinicoradiologic finding is currently lacking in autopsy-confirmed normal brains. To determine the histopathologic basis of WMH seen on magnetic resonance imaging, we studied the relationship between postmortem fluid-attenuated inversion recovery (FLAIR) intensity and neuropathologic markers of WM lesions (WMLs) that correspond to WMH in cognitively normal aging brains. Samples of periventricular (n = 24), subcortical (n = 26), and normal-appearing WM (NAWM, n = 31) from 4clinically and pathologically confirmed normal cases were examined. The FLAIR intensity, vacuolation, and myelin basic protein immunoreactivity loss were significantly higher in periventricular WML versus subcortical WML; both were higher than in NAWM. The subcortical WML and NAWM had significantly less axonal loss, astrocytic burden, microglial density, and oligodendrocyte loss than those of the periventricular WML. Thus, vacuolation, myelin density, and small vessel density contribute to the rarefaction of WM, whereas axonal density, oligodendrocyte density, astroglial burden, and microglial density did not. These data suggest that the age-related loss of myelin basic protein and the decrease in small vessel density may contribute to vacuolation of WM. Vacuolation enables interstitial fluid to accumulate, which contributes to the prolonged T2 relaxation and elevated FLAIR intensity in the WM.


Subject(s)
Brain/pathology , Magnetic Resonance Imaging , Nerve Fibers, Myelinated/pathology , Postmortem Changes , Aged , Aged, 80 and over , Female , Humans , Image Processing, Computer-Assisted , Male
4.
Rinsho Shinkeigaku ; 51(8): 603-7, 2011 Aug.
Article in Japanese | MEDLINE | ID: mdl-21878728

ABSTRACT

We investigated fixed basal ganglia specimens, including globus pallidus and putamen, with 21.1-Tesla MRI allowing us to achieve a microscopic level resolution from a patient with pathologically confirmed dementia with Lewy bodies (DLB) and a neurologically normal control case. We acquired T2 and T2 * weighted images that demonstrated diffuse and patchy lower intensities in the basal ganglia compared to control. There are several paramagnetic substances in brain tissue that could potentially reduce both T2 and T2 * relaxation times, including ferritin, iron (Fe3+), manganese, copper and others. Because iron is most abundant, low intensities on T2 and T2 * weighted images most likely reflect iron deposition. Iron, especially Fe3+, deposition was visible in the pathological specimens stained with Prussian blue after images were obtained. Although radiological-pathological comparisons are not straightforward with respect to either the MRI signal or relaxation quantification, there appears to be a correlation between the relative increase in iron as assessed by Prussian blue staining and the decrease in T2 * value between the DLB and control specimens. As such, this exceptionally high field MRI technique may provide details about the role that iron deposition plays either directly or indirectly as a biomarker in neurodegenerative processes.


Subject(s)
Lewy Body Disease/pathology , Magnetic Field Therapy/methods , Aged, 80 and over , Basal Ganglia/pathology , Humans , Iron/analysis , Male
5.
Parkinsonism Relat Disord ; 16(5): 329-33, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20219408

ABSTRACT

OBJECTIVES: We sought to determine concentrations of total and labile iron in substantia nigra from patients with Parkinson disease and from controls to assess if oxidative stress is triggered by an increased concentration of iron. METHODS: Total iron concentration in the whole substantia nigra was evaluated in 17 parkinsonian and 29 control samples. Concentrations of labile iron and copper were assessed in 6 parkinsonian and 8 control samples. The total iron concentration, the Fe(2+)/Fe(3+) ratio, and iron-binding compounds were determined by Mössbauer spectroscopy. Labile iron and copper were measured by electrothermal atomic absorption spectrometry. Activity of reactive oxygen species was evaluated by visible light fluorescence. RESULTS: The labile iron concentration was significantly higher and corresponded to significantly higher reactive oxygen species activity in parkinsonian vs control samples. No significant difference was found in the total concentrations of copper or iron in the whole substantia nigra between parkinsonian and control samples. Mössbauer spectroscopy detected no Fe(2+) in any samples. CONCLUSIONS: The substantia nigra of parkinsonian patients contained more labile iron compared with that of controls. This labile iron generated higher reactive oxygen species activity. The oxidative stress damage in parkinsonian substantia nigra may be related to an excess of labile iron and not of the total iron in the diseased tissue.


Subject(s)
Iron/metabolism , Parkinsonian Disorders/pathology , Reactive Oxygen Species/metabolism , Substantia Nigra/metabolism , Copper/metabolism , Female , Humans , Iron-Binding Proteins/metabolism , Male , Spectrophotometry, Atomic/methods
9.
J Neural Transm (Vienna) ; 115(7): 993-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18368284

ABSTRACT

Transcranial sonography (TCS) is a valuable tool in the diagnosis of Parkinson's disease (PD). However, substantia nigra hyperechogenicity (SN+) in TCS has been shown to be also evident in about 8-10% of healthy persons. Neuroimaging studies and slight motor deficits in subjects with SN+ indicate functional impairment of the nigrostriatal system associated with the ultrasound sign. We questioned, whether SN+ may also be associated with neuropsychological deficits and whether there is a relation to other PD premotor markers. Thirty-six subjects with SN+ and 34 control persons (SN-) older than 50 years were investigated. The delayed verbal memory recall (LogII) of subjects with SN+ was significantly reduced compared to the performance of the control group (P=0.02). Binary logistic regression analysis revealed that, besides UPDRS-III (P<0.001) and positive family history for PD (P<0.01), LogII (P<0.05) seems to be independently associated with SN+.


Subject(s)
Cognition Disorders/pathology , Geriatric Assessment , Substantia Nigra/diagnostic imaging , Ultrasonography, Doppler, Transcranial , Aged , Case-Control Studies , Cognition Disorders/diagnostic imaging , Female , Humans , Male , Middle Aged , Neurologic Examination , Neuropsychological Tests , Odds Ratio , Statistics, Nonparametric
10.
FASEB J ; 22(5): 1327-34, 2008 May.
Article in English | MEDLINE | ID: mdl-18162487

ABSTRACT

Genetic variability in the promoter and 3' region of the SNCA gene coding alpha-synuclein modulates the risk to develop sporadic Parkinson's disease (PD). Whether this is mediated by regulating alpha-synuclein expression levels remains unknown. Therefore, we analyzed levels of alpha-synuclein in blood and human post mortem brain tissue including the substantia nigra using quantitative real-time reverse transcriptase-polymerase chain reaction and enzyme linked immunosorbent assay in vivo. Single nucleotide polymorphism (SNP) rs356219, a tagging SNP for a disease-associated haplotype in the 3' region of the SNCA gene, has a significant effect on SNCA mRNA levels in the substantia nigra and the cerebellum. Further, the "protective" genotype 259/259 of the PD-associated promoter repeat NACP-Rep1 is associated with lower protein levels in blood than genotypes 261/261, 259/261, and 259/263. In conclusion, we provide evidence that alpha-synuclein levels are influenced by genetic variability in the promoter and 3' region of the SNCA gene in vivo.


Subject(s)
Brain Chemistry/genetics , Polymorphism, Single Nucleotide , alpha-Synuclein/analysis , alpha-Synuclein/genetics , Adult , Aged , Aged, 80 and over , Cerebellum/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Genotype , Gyrus Cinguli/metabolism , Humans , Leukocytes, Mononuclear/chemistry , Male , Medulla Oblongata/metabolism , Middle Aged , Parkinson Disease/genetics , Promoter Regions, Genetic/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Substantia Nigra/metabolism , Time Factors , alpha-Synuclein/blood
12.
J Neurol ; 254(5): 613-6, 2007 May.
Article in English | MEDLINE | ID: mdl-17415511

ABSTRACT

Hyperechogenicity of the substantia nigra (SN) has been found to be a typical sign in idiopathic Parkinson's disease (PD), prevalent in more than 90% of affected individuals. To see whether SN hyperechogenicity is also characteristic for monogenetically caused PD, we investigated PD patients with alpha-synuclein, LRRK2, parkin, PINK1 and DJ-1 mutations by transcranial sonography (TCS). In all these patients the area of SN echogenicity was significantly larger than in healthy controls, but smaller, than in idiopathic PD. As SN hyperechogenicity could be related to an increased iron content of the SN, these findings suggest that iron may play a less significant role in the pathogenesis of monogenetically caused compared to idiopathic PD.


Subject(s)
Parkinson Disease/classification , Parkinson Disease/diagnostic imaging , Ultrasonography, Doppler, Transcranial/methods , Aged , Female , Humans , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 , Male , Mutation , Parkinson Disease/genetics , Parkinson Disease/pathology , Protein Kinases/genetics , Protein Serine-Threonine Kinases/genetics , Substantia Nigra/diagnostic imaging , Substantia Nigra/pathology , Ubiquitin-Protein Ligases/genetics , alpha-Synuclein/genetics
13.
Mov Disord ; 22(2): 187-92, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-17133515

ABSTRACT

Pathological studies demonstrate a decreased iron content in the substantia nigra (SN) contributing to the pathophysiology of restless legs syndrome (RLS). SN echogenicity as measured by transcranial sonography (TCS) correlates with the SN iron content. The objective of this study was to determine a critical value to define SN hypoechogenicity as a potential marker for RLS. There were 49 RLS patients (39 idiopathic, 10 secondary) and 49 age- and sex-matched controls who underwent TCS by 2 independent and blinded examiners to determine the area of SN echogenicity. We found that SN echogenicity is significantly decreased in RLS patients compared to healthy controls (P < 0.001). SN hypoechogenicity (sum area of SN echogenicity of both sides < 0.2 cm(2)) is more common in idiopathic than in secondary RLS patients. The area under curve for idiopathic RLS versus controls (receiver operating characteristics) is 0.91, specificity is 0.90, and sensitivity is 0.82. TCS provides an interesting additional instrument in the diagnosis of RLS. Therefore, SN hypoechogenicity (SN sum area < 0.2 cm(2)), which is supposed to indicate a decreased SN iron content, is a marker for RLS. Further studies are needed to investigate its significance for the pathophysiology of this frequent movement disorder and possible clinical applications.


Subject(s)
Restless Legs Syndrome/diagnostic imaging , Restless Legs Syndrome/physiopathology , Substantia Nigra/diagnostic imaging , Substantia Nigra/physiopathology , Ultrasonography, Doppler, Transcranial/methods , Female , Homeostasis/physiology , Humans , Iron Deficiencies , Male , Middle Aged , ROC Curve , Restless Legs Syndrome/epidemiology , Severity of Illness Index , Substantia Nigra/metabolism
14.
Mov Disord ; 21(10): 1763-5, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16874758

ABSTRACT

Transcanial sonography (TCS) is increasingly applied in the diagnosis of Parkinson's disease (PD), but investigator bias may influence the results of examination. Blinding the sonographer to the clinical diagnosis of 42 PD patients and 35 controls, we obtained a positive predictive value of 85.7% and a negative predictive value of 82.9% in the diagnosis of PD solely by interpreting the results of TCS, indicating that TCS is a valuable additional tool in the diagnosis of PD.


Subject(s)
Echoencephalography , Parkinson Disease/diagnostic imaging , Aged , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Reference Values , Sensitivity and Specificity , Substantia Nigra/diagnostic imaging
15.
Neurotox Res ; 9(1): 1-13, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16464747

ABSTRACT

A central role of iron in the pathogenesis of Parkinson's disease (PD) has been discussed for many years. So far, however, a biomarker indicating increased iron levels in the substantia nigra (SN) in PD patients has been missing. Performing transcranial ultrasound we detected an increased area of SN echogenicity as a typical echofeature in PD, visible already in the early stages of the disease and in subjects with subclinical impairment of the nigrostriatal system. Animal studies and post mortem analyses of human brain tissue revealed that this echofeature is associated with increased iron levels of the substantia nigra as well as a reduced neuromelanin content. The apparently autosomal dominant inheritance of this echofeature in relatives of patients with idiopathic PD indicates a primary role of disturbances of iron metabolism in PD. Consequently performed mutation analyses in genes involved in brain iron metabolism lead to the discovery of specific mutations in the ferritin-H, IRP2 and HFE gene in single PD patients. Moreover, variations in the ceruloplasmin gene were found to be associated with PD or SN hyperechogenicity. Functional relevance of some of these mutations for iron metabolism could be proven. Therefore, SN hyperechogenicity can be regarded as biomarker for both: impairment of the nigrostriatal system and increased iron levels of the SN. Future studies aim at substantiating the hypothesis that healthy subjects with SN hyperechogenicity indeed represent a population at risk for nigrostriatal degeneration, which would have a significant impact on therapeutical options.


Subject(s)
Iron/metabolism , Parkinson Disease/metabolism , Parkinson Disease/radiotherapy , Ultrasonography/methods , Animals , Biomarkers , Ceruloplasmin/genetics , Ferritins/genetics , Ferritins/metabolism , Genetic Variation , Humans , Isocyanates/metabolism , Models, Biological , Mutation , Parkinson Disease/genetics , Substantia Nigra/diagnostic imaging , Substantia Nigra/metabolism
16.
Mov Disord ; 21(1): 94-8, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16114024

ABSTRACT

Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound marker may give any implications for the rate of PD progression, we sonographically investigated 16 PD patients in whom the rate of progression had been determined by serial 18-fluorodopa positron emission tomography over a follow-up period of 65.7+/-26.7 months. We found a significant negative correlation between the right-to-left averaged SN echogenic size and the rate of disease progression in the caudate nucleus and in the putamen. There was a tendency towards a younger age at symptom onset in patients with SN hyperechogenicity. It may therefore be hypothesized that a differing influence of factors determining SN echogenicity early in life and impairing forces occurring later in life may account for different pathogenetic subgroups of idiopathic PD.


Subject(s)
Echoencephalography , Parkinson Disease/diagnostic imaging , Substantia Nigra/diagnostic imaging , Adult , Aged , Disease Progression , Female , Humans , Male , Mathematical Computing , Middle Aged , Positron-Emission Tomography , Prognosis , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...